Divestiture

A mining giant pays Canada's largest-ever environmental fine for past pollution while investing hundreds of millions to secure a cleaner future.

In a shift from celebrity endorsements, Ronald McDonald House names a family who used its services as its first-ever global spokesfamily.

Forty dogs, rescued from a horrific cruelty case and a unique prison program, begin their long road to recovery with Animal Rescue Corps in Tennessee.

The LiDAR maker saw Q1 revenue fall but is entering the defense market, launching 1km-range sensors, and reaffirming its full-year financial outlook.

A new report reveals a chasm between brand claims and reality, with prohibited cotton surging and consumer trust at an all-time low. Is science the only answer?

AutoCanada posts a Q1 loss amid a soft market, accelerating its U.S. dealership sale and relying on new leadership and its collision arm for recovery.

A major pickleball patent dispute ends as JOOLA and Paddletek settle, but the legal battle for nine other brands is just beginning. What does this mean?

At LIU's Centennial Commencement, billionaire Ray Dalio offered grads more than advice—he gifted a scholarship for Transcendental Meditation.

With a 2027 deadline looming and prices soaring, a junior miner's Nevada project could become vital for America's defense supply chain.

As Dye & Durham preps its Q3 earnings call, all eyes are on its transformation plan after a streak of declining revenue and significant net losses.

The German insurer posts a record €4.5B Q1 profit, leveraging AI and strong P&C results to navigate a volatile market and boost shareholder returns.

After 18 years, a judge ruled prosecutors hid key scientific evidence in the case of Deborah Nicholls, convicted of a fire that killed her three children.

A staggering 50% of first-time C-suite leaders fail within 18 months, costing billions. A new book by a veteran advisor aims to fix this preparation gap.

The sale of The Blake at Tyler to a REIT highlights a national trend: intense investor demand for upscale, resort-style senior living communities.

The medtech firm reports a 19% revenue surge and a return to profitability, validating its new pure-play strategy focused on the surgical market.

Amid a $10M loss and a major foreclosure, Bioceres slashes costs and bets on a strategic pivot. Can the ag-tech firm navigate its financial storm?

Despite a revenue dip, the business services giant posted major gains in profitability and cash flow, pointing to early wins in its new strategic overhaul.

Freshly rebranded Keel Infrastructure posts huge Q1 losses, but a $533M war chest and a 2.2GW pipeline show its real focus: the AI data center boom.

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

CGBD resets its dividend amid market volatility, betting on joint ventures and wider spreads for future growth. Is this a smart move for long-term stability?